Lindbrook Capital’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.06K | Hold |
228
| – | – | ﹤0.01% | 1946 |
|
|
2024
Q4 | $4.51K | Hold |
228
| – | – | ﹤0.01% | 2030 |
|
|
2024
Q3 | $5.7K | Sell |
228
-457
| -67% | -$11.4K | ﹤0.01% | 1958 |
|
|
2024
Q2 | $12.8K | Buy |
685
+25
| +4% | +$467 | ﹤0.01% | 1491 |
|
|
2024
Q1 | $13K | Buy |
660
+2
| +0.3% | +$39 | ﹤0.01% | 1421 |
|
|
2023
Q4 | $11.5K | Buy |
658
+49
| +8% | +$859 | ﹤0.01% | 1472 |
|
|
2023
Q3 | $10.6K | Buy |
609
+29
| +5% | +$504 | ﹤0.01% | 1385 |
|
|
2023
Q2 | $8.17K | Hold |
580
| – | – | ﹤0.01% | 1589 |
|
|
2023
Q1 | $6.24K | Buy |
580
+123
| +27% | +$1.32K | ﹤0.01% | 1755 |
|
|
2022
Q4 | $6.85K | Sell |
457
-26
| -5% | -$389 | ﹤0.01% | 1639 |
|
|
2022
Q3 | $6K | Buy |
483
+460
| +2,000% | +$5.71K | ﹤0.01% | 1564 |
|
|
2022
Q2 | $0 | Buy |
+23
| New | – | ﹤0.01% | 2642 |
|